https://www.selleckchem.com/pr....oducts/apo866-fk866.
iotherapy, performance of minimally invasive surgery was not associated with worse survival (HR 0.90, 95% CI 0.73 to 1.11). CONCLUSIONS In this retrospective analysis, minimally invasive surgery in patients with stage II endometrial carcinoma was associated with superior short-term peri-operative outcomes and improved 3-year overall survival. © IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) have transformed the treatment landscape in fron